FPT-CORPORATION
24.4.2024 06:36:34 CEST | Business Wire | Press release
FPT Corporation signed Letter of Cooperation with the United States Agency for International Development’s (USAID) Vietnam Low Emission Energy Program II (V-LEEP II), with the goal of supporting the corporation in achieving the Net Zero target by 2040, a decade earlier than Vietnam's commitment. FPT is Vietnam’s first technology firm to collaborate with V-LEEP II.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240423349833/en/
The signing ceremony was attended by FPT Corporation Senior Executive Vice President Nguyen The Phuong, FPT Software Senior Executive Vice President Nguyen Khai Hoan, and USAID/Vietnam Deputy Mission Director Bradley Bessire (Photo: Business Wire)
In accordance with the agreements, V-LEEP II will provide technical assistance to FPT from April 2024 to April 2025 as the corporation formulates a plan to execute its net-zero commitments. This entails providing a comprehensive understanding of Net Zero strategy, as well as general insights about advanced clean energy development, such as the Direct Power Purchase Agreement mechanism, Renewable Energy Certificates, Battery Energy Storage Systems, Rooftop Solar Development for Self-consumption, and other relevant topics. In addition, V-LEEP II will also support FPT with capacity-building programs in a variety of areas and connect FPT with leading experienced renewable energy developers to gain more experience in the deployment and use of advanced clean energy, thereby reducing greenhouse gas emissions and becoming carbon neutral.
“Our collaboration with USAID aligns with our commitment to spearheading initiatives to mitigate the impact of greenhouse gas emissions in Vietnam. We aim to positively impact the living, working, and learning environments for both 1 million FPT employees globally by 2035 and society at large. FPT will steadfastly pursue the mission of establishing a resilient, happy global corporation,” said FPT Senior Executive Vice President Nguyen The Phuong.
FPT’s subsidiary FPT Software also signed the Letter of Cooperation with USAID’s V-LEEP II. “FPT Software has the mission to support the growth of the nation, and we are also committed to aligning with our global clients on sustainable development efforts. FPT Software cares about the future of our people and the planet, and we strive to be an active member of a green, sustainable ecosystem. The support from USAID is important for us to achieve this goal,” said FPT Software Senior Executive Vice President Nguyen Khai Hoan.
“FPT is the future of Vietnam business. It is powerful that FPT is thinking about the future, and I hope that will positively influence Vietnam’s younger generations and business community. We are excited to be part of this progress together with FPT towards a sustainable future,” shared at the event today by USAID/Vietnam Deputy Mission Director Bradley Bessire.
FPT is actively conducting measures and activities to reduce energy consumption and reduce greenhouse gas emissions, notably building green and environment-friendly workplace, planting trees for carbon offsets, offering discounts for employees buying electric vehicles, and ensuring all employees receive annual training on environmental protection. Leveraging its technology expertise, FPT constantly implements internal digital transformation towards a paperless business model, with more than 100,000 e-contracts signed in 2023, an increase of 6.6% compared to 2022. FPT is the trusted partner in green transformation, providing consulting services and comprehensive solutions related to ESG, such as the carbon audit solution VertZéro. FPT recently published its ESG report, highlighting its ongoing commitment to the highest standards of sustainable development through four key areas, including Environmental Sustainability, Work Environment, Social Responsibility, and Excellent Governance.
About FPT Corporation and FPT Software
FPT Corporation is a global technology corporation and a leader in consulting, providing, and deploying technology and telecommunications services and solutions. It records a global workforce of 48,000+ and total revenue of $2.17 billion (2023).
FPT Software, a subsidiary of FPT Corporation, is a global technology and IT services provider headquartered in Vietnam, with $1 billion in revenue (2023) and over 30,000 employees in 30 countries.
The company champions complex business opportunities and challenges with its world-class services in Advanced Analytics, AI, Digital Platforms, Cloud, Hyperautomation, IoT, Low-code, and so on. It has partnered with over 1,000+ clients worldwide, 91 of which are Fortune Global 500 companies in Aviation, Automotive, Banking, Financial Services and Insurance, Healthcare, Logistics, Manufacturing, Utilities, and more. For more information, please visit https://fptsoftware.com/
About USAID V-LEEP II Program
USAID/Vietnam supports an “open, prosperous, and secure Vietnam that is effective and inclusive in tackling its own development challenges.” USAID/Vietnam’s flagship clean energy program, the Vietnam Low Emission Energy Program II (V-LEEP II), aims to advance Vietnam’s transition to a clean, secure, and market-based energy sector through three main objectives: (1) Increased deployment of advanced energy systems, (2) Improved energy sector performance, and (3) Increased energy sector competition.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240423349833/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom